chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within 24 hours of receiving vaccine, I experienced swelling in my feet and hands (more swelling on my left hand and foot), pain in both legs.  Pins and needles, tingling and weakness also present in my legs.  This lasted for 2 weeks with no relief. I then went to the ER and no tests indicated it was any autoimmune or any other trigger.
Went today to get my Phizer Booster; pharmacy tech told me I should report my side effects from JJ Vaccine.  11:30pm that night 04/06/21 I woke up to let my dogs out to take care of there business.  When I stood up I had very bad shakes; chills and body aches.  Had a hard time walking to let my dogs out.  After 30 minutes went back to sleep still in same condition.  Woke up at 4:30 am to get ready for work had no shakes but strong chills and body aches.  My whole back was very sore top to bottom.  Went to work for a few hours then came home.  Back was very sore; hard time walking.  The next few days side effects chills, body aches, sore back slowly went away. 4 days later back to my normal self.  The JJ vaccine is a modified cold virus that got zapped with a Jurasic Park.  Very strong!
Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) UKNOWN. On an unknown date, the patient experienced FATIGUE (Fatigue). At the time of the report, FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       On 25 Feb 2021, the consumer reported a female friend who experienced fatigue after receiving an injection of the Moderna COVID-19 vaccine.  No concomitant medications were reported.  Treatment information was not provided.
48 hrs p/vax, devel urticaria, pain & swelling of arms, hands, ankles & feet lasting 4 days;
Received 0.6ml instead of the ordered 0.3ml. No adverse reactions noted from the member
Vesicles in face that came in crops. There is one open vesicle that measures about 1 cm in diameter.
administered expired vaccine to the patient, after the manufacture date of expiration; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered expired vaccine to the patient, after the manufacture date of expiration) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 10-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered expired vaccine to the patient, after the manufacture date of expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered expired vaccine to the patient, after the manufacture date of expiration) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  Date the vial was initially stored in the refrigerator reported as unknown. Number of doses/vials was reported as 168 doses. The vial did not undergo any temperature excursions.  Treatment information was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Follow-up received and included no significant information.
10/28/11 Administered Td that expired on 10/15/11. 10/28/11 Admnistered FluMist patient had received TIV Fluzone on 10/13/11.
Redness, warmth swelling 8 x 12 cm to (L) upper arm, itching into, fever, on/off x 2 days, headache & neck tightness, dizziness with turning head. Shortness of breath.
Administration of an expired dose; no adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administration of an expired dose) and NO ADVERSE EVENT (no adverse event) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. ASKU) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administration of an expired dose) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administration of an expired dose) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Administration of an expired dose).    Concomitant products were not reported.  It was reported that had an issue with moderna injection about how long it went past expiry date. Product associated with event was unknown.   Treatment medications were not reported.   Reporter did not allow further contact
Soreness at the injection site 2days post injection through 9 days at time of evaluation.
patient received three doses of the vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of EXTRA DOSE ADMINISTERED (patient received three doses of the vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced EXTRA DOSE ADMINISTERED (patient received three doses of the vaccine). On 10-Mar-2021, EXTRA DOSE ADMINISTERED (patient received three doses of the vaccine) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medication reported. No treatment information was provided.  This report refers to a case of Extra dose administered for mRNA-1273 (Lot number: Unknown) with no associated AEs.; Sender's Comments: This report refers to a case of Extra dose administered for mRNA-1273 (Lot number: Unknown) with no associated AEs
Woke up at 12:30 a.m. with severe chills and aches - put on socks and heavy sweatshirt and went back to bed.  When I woke at 7 a.m. I had body aches - difficult to walk,  was off-balance,  exhaustion, nauseousness, vomited immediately after taking my morning vitamins and had a headache.   I am a very active and healthy and strong person - these side effects landed me in bed all day.  Today, October 4, I'm feeling much better with a slight headache and body aches and nauseousness and feeling a bit tired.   I'm hoping I am on the mend.  I called my PCP who told me to take Tylenol and call if my condition worsened.
pt states that she immediately noticed her left arm started tingling and getting numb.  This sensation started spreading from her arm down to her left leg.  She then noticed this sensation moving up into the left side of her face.  She started feeling out of it while driving home.  she got home her left but cheek was hurting like she had the vax in that area but she had it in the arm.  She went for a walk, took 2 advil and went to bed.  On 3/25/21 she still has some numbness and tingling on the left side of her body. Her left arm down to her hand still hurts.
Severe stabbing burning Eye Pain and Blindness.  Fluids draining from nose and eyes..  Body tremors and total body pain and Headache.
Felt intoxicated; Severe whole body pain; Chills; Headache; Unable to sleep; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 26 year-old female patient received bnt162b2 (BNT162B2) (Lot number: ew0153) as dose 1, single and (Lot number: ew0176) as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: SAVELLA; LEXAPRO; PROPANOLOL [PROPRANOLOL]; JUNEL. The following information was reported: FEELING ABNORMAL (non-serious) with onset 17Dec2021 21:00, outcome "not recovered", described as "Felt intoxicated"; PAIN (non-serious) with onset 17Dec2021 21:00, outcome "not recovered", described as "Severe whole body pain"; CHILLS (non-serious) with onset 17Dec2021 21:00, outcome "not recovered", described as "Chills"; HEADACHE (non-serious) with onset 17Dec2021 21:00, outcome "not recovered", described as "Headache"; INSOMNIA (non-serious) with onset 17Dec2021 21:00, outcome "not recovered", described as "Unable to sleep". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of feeling abnormal, pain, chills, headache, insomnia. The patient had not taken other vaccine in 4 weeks. The patient received dose 3 (Lot number: fd0809) on 18Dec2021 12:00 pm.  No follow-up attempts possible. No further information is expected.
developed a rash on both forearms.  rash resolved by 1700 on 1/5/21.
A nurse reported the occurrence of injection site cellulitis in a 18-month-old female who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix) for prophylaxis.  The subject's medical history, concurrent conditions, and concurrent medications were unknown.  On 02/11/2003, the subject received an Infanrix injection (lot number DTPA578A9).  Subsequently, the subject received an injection site cellulitis; the diagnosis was made by the vaccine provider.  The reporting nurse did not know if the vaccine provider had examined the subject or prescribed any medication.  The reporting nurse stated that the event was possibly related to Infanrix administration.  As of 02/18/2003, the outcome of the event was unknown.  Comment:  This is one of five subjects, out of 19 children immunized, who developed injection site cellulitis following receipt of Infanrix lot DTPA578A9.  Please see reports A0398143A, A0398144A, A0398145A, and A0398146A.
Extreme fatigue & exhaustion Received 2nd dose pfizer covid vaccine on May 7th, three weeks from 1st dose, April 16. Sudden inexplicable bruises, some single, some small,, others quite large, others in clusters, appeared on both lower extremities alomg with red petechiae, all around inside, outside, front and back of legs from ankles to upper thigh/buttocks. First single bruise with red dot in middle appeared within 2wks of 2nd dose, and from May through end of August 2021, numerous other bruises appeared, without injury occurring. Literally looked like beaten with a bat. Subject is a 20yo female. No underlying medical conditions other than prior history of presumed perinatal ischemic stroke resulting in right sided hemiplegia cerebral palsy, mutation of MTHFR and Factor V Leiden positive. Pediatrician ran extensive blood work, all of which was unremarkable. Referring to hematology for further evaluation. As of September 14, 2021, only remnants of some bruises remain, primarily around inside of and top of knees. No new bruises reported or observed since September 1, 2021. Spontaneous single and clusters of bruises lasted approximately three months. Further evaluation by hematology to happen sometime in September, appointment pending. Adter the 2nd Pfizer-BioNTech Covid shot, patient also chronically complained of nausea, stomach aches, headaches, extreme fatigue and feeling exhausted, regardless of how.much sleep, symptoms persist to as of September 14, 2021. Additional items of note, patient has appeared unusually pale with chronic blue/purplish hue under eyes, and sickly, for lack of better descriptive word. Patient has no confirmed prior covid positive test, although very early in March 2020, younger sibling, 15yo.at time, was symptomatic prior to mask mandates, stay at home order and schools closing, with confirmed positive covid-19 test and antibody test first done May 24th, 202. Family advised by physician to presume entire family is covid positive. Contact wiith covid positive sibling was extremely close pior, during and throughout stay at home lock-down and continued even after positive covid and positive antibody tests May 24th, 2020
Positive COVID Test after vaccination; This spontaneous case was reported by a physician and describes the occurrence of COVID-19 (Positive COVID Test after vaccination) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced COVID-19 (Positive COVID Test after vaccination). At the time of the report, COVID-19 (Positive COVID Test after vaccination) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Cross Linked with Case MOD21-032138 and MOD21-036065. Patient received antibody treatment for the infection and have since recovered. No relevant concomitant medications were reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship Unlikely.
Cramp in right calf for about 4 days. Then pain when to both legs, making it real hard to walk. After about 8 days pain added to both shoulders and arms. This is when I stated going back to my doctor.
First symptom occurred upon waking at 7am. Was confused and having delirious thoughts what you might call a "fever dream". Checked temp but had no fever. Went back to bed. Waking several hours later, was fatigued with a slight headache, but still no fever. By 12pm, had a 101.3 fever, joint and body aches, and general fatigue. Took 2 acetaminophen around 1pm. Slept on and off until 8pm at which point I felt much better. Symptoms were completely gone by 10pm.
Narrative: Patient is a 74 year-old male who received his first COVID vaccine on 2/16 and his second dose on 3/11. On 4/19, patient presented to the emergency department with lower extremity swelling, and was found to have bilateral LE DVTs. He was started on apixaban (started with VTE initiation dose) for his event. Per our ID pharmacy evaluation: Vaccine induced thrombosis has been shown to be associated with the Johnson and Johnson vaccine (and Astrazeneca though this is not available for use in this country) which is an adenovirus vaccine. VIT typically occurs within 30 days of vaccine receipt and is often accompanied by low platelets. This association between vaccine and thrombosis has not been shown with the MRNA vaccine (Pfizer or Moderna). It is unlikely that DVT is 2/2 COVID vaccine. Patient received MRNA vaccine which has not been shown to be associated with VIT. Additionally PLTS are wnl and patient has other risk factors for thrombosis such as obesity (BMI ~34), paraplegia (decreased mobility), history of prior thrombosis, and history of cancer. Event is being reported as an ADR given it was within 6 weeks of the vaccine administration.
Pt vaccinated @ 0900 on 15Oct2012 with HPV and TDAP. Per pt within 24hrs had c/o itchy discomfort with pain and swelling. Reported to clinic on 17Oct2012 @ 1400 with c/o itchy discomft bilat upper extremities. Concerns becasue son had allergy to Tdap vaccine causing febrile seizures.
Patient developed a case of shingles after the second varicella shot. Symptoms included rash and pain on one side of body, back, neck & arm areas. Doctor was notified and medicine was given to her to lessen symptoms. Also of note - she had a mild case of chicken pox at the age of 4 months that she caught from her older sister. Her pediatrician at that time (1996) said this was the equivalent of having the vaccine and she would have immunity to the chicken pox. It was discovered at a check-up when she was 17 years old that she did not have the antibodies in her blood & should therefore get the varicella vaccine. She did not have an adverse reaction to the 1st shot which was given on 1/7/2014, but then got shingles after the second shot.
IMPROPER STOAGE OF ACCINE.  PATIENT HAD NO ADVERSE REACTIONS
Began with itchy feet and hands with nausea. Face began to swell around lips and eyes. Whole body became itchy and covered in hives.
Rash around mouth, chest and back (3/25/19). Fever in evening and at night that got as high as 102.3 degrees (3/25/19). Swelling and blistering at injection site over 3" in length (3/25/19-current). Mild fever (3/26/19). Instability walking - child would lose balance or crash into objects - abnormal behavior for child (3/25/19-3/26/19).
Muscles EVERYWHERE ache. Back, limbs neck etc.  Totally incapacitated  me . Burn sensation on patches of my skin in several areas.  Headache that would not go away. Shooting pains in the toes.
Large rash (about 4 inches in diameter) appeared at injection site 8 days post-vaccine. Lasted about 3 days.
a second episode of body ach9; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (a second episode of body ach9) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (a second episode of body ach9). At the time of the report, MYALGIA (a last episode of body ach9) outcome was unknown.            No treatment medications were provided No concomitant medications were provided
Fatigue; Severe body aches; Headache; Severe injection site pain; Chills; High fever (101 degrees Fahrenheit); This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0177) via an unspecified route of administration in the left arm on 20May2021 at 12:15 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patients' medical history was reported as none. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 29Apr2021 at 12:15 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 21May2021 at 00:30, the patient experienced fatigue, severe body aches, headache, severe injection site pain, chills and high fever (101 degrees Fahrenheit). Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fatigue, severe body aches, headache, severe injection site pain, chills and high fever (101 degrees Fahrenheit) were resolved on an unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
itching/itching of skin; head fog/"feeling foggy" to frontal head/funny feeling; dizziness; hypoglycemia; hypotension; generalized rash; This is a spontaneous report from a non-contactable Other HCP. A 65-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EP7534), dose 2 via an unspecified route of administration on 26Mar2021 (at the age of 65-years-old) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: not reported), dose 1 via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation and experienced head itching. On 26Mar2021, during the patient's 15-minute waiting period after the injection, the patient began to experience itching and head fog. She denied rash, hives, welts, difficulty breathing, difficulty swallowing, wheezing, throat tightness, facial swelling, lip swelling and tongue swelling. She had mild reaction to her fist COVID vaccine. She had some head itching on right side. Resolved without medication. Initially with complaints of "feeling foggy" to frontal head Also feeling itching more to right side of body. Patient complains of itching of skin and dizziness (when up to bathroom) on an unspecified date in 2021. The patient received treatment included: antihistamines, water and snacks. The follow up response to treatment was good. The patient discharge: Stable to go home and follow up with PCP. On an unspecified date in 2021, she had systemic reaction (hypoglycemia, hypotension, generalized rash). The Benadryl given for itching significant improvement in this noted continues to complain of having "funny feeling" and fog. Denies headache and does not wishes of migraine headaches, but this was not similar. The patient received the treatment for the events. The outcome of the event itching/itching of skin was recovering. The outcome of the event head fog/"feeling foggy" to frontal head/funny feeling was not recovered and outcome of the other events was unknown.  No follow-up attempts are possible. No further information is expected.
Body aches, headache, loss of taste and smell for about 5 hours, fatigue but unable to sleep, hot and cold flashes
Pt had MS, in remission, 4-5 days after injection. Pt had severe vertigo, balance problems and severe fatigue, lasting 4 weeks. Treated with low dose valium. Pt refused steroids.
15 year old patient inadvertently given pfizer COVID vaccine booster. Booster currently approved for age 16+